Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Ogaki, Gifu, Japan.
Ultrasound Imaging Center, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan; Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.
Ultrasound Med Biol. 2019 Oct;45(10):2679-2687. doi: 10.1016/j.ultrasmedbio.2019.05.033. Epub 2019 Jul 3.
We investigated the diagnostic capability of the proprietary attenuation imaging (ATI) modality found on some Canon Medical Systems Corp. ultrasound scanners to detect histologically diagnosed steatosis in 148 patients. ATI values increased significantly with increasing steatosis grade (p < 0.001). The diagnostic values (area under the receiver operating characteristic curve) of ATI for steatosis grades ≥ 1 (5%-33% of hepatocytes), ≥ 2 (33%-66% of hepatocytes) and 3 (> 66% of hepatocytes) were 0.85, 0.91 and 0.91. In addition, ATI values increased significantly with increasing steatosis grades (p = 0.002) even in obese patients (n = 41). The diagnostic values of ATI for steatosis grades ≥ 1, ≥ 2 and 3 in obese patients were 0.72, 0.72 and 0.78. Furthermore, ATI values increased significantly with increasing steatosis grade (p < 0.001) in patients with non-alcoholic fatty liver disease (NAFLD) (n = 38). The diagnostic values of ATI for steatosis grades ≥ 1, ≥ 2 and 3 in NAFLD patients were 0.77, 0.88 and 0.86. In conclusion, the ATI method showed good diagnostic capability for the detection of hepatic steatosis.
我们研究了某些佳能医疗系统公司的超声扫描仪上特有的衰减成像(ATI)模式的诊断能力,以检测 148 名患者的组织学诊断为脂肪变性。ATI 值随着脂肪变性程度的增加而显著增加(p<0.001)。ATI 对脂肪变性程度≥1(5%-33%肝细胞)、≥2(33%-66%肝细胞)和 3(>66%肝细胞)的诊断价值(接受者操作特征曲线下的面积)分别为 0.85、0.91 和 0.91。此外,即使在肥胖患者(n=41)中,ATI 值也随着脂肪变性程度的增加而显著增加(p=0.002)。ATI 对肥胖患者脂肪变性程度≥1、≥2 和 3 的诊断价值分别为 0.72、0.72 和 0.78。此外,ATI 值随着非酒精性脂肪性肝病(NAFLD)患者脂肪变性程度的增加而显著增加(p<0.001)(n=38)。ATI 对 NAFLD 患者脂肪变性程度≥1、≥2 和 3 的诊断价值分别为 0.77、0.88 和 0.86。总之,ATI 方法对肝脂肪变性的检测具有良好的诊断能力。